{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:48:28Z","timestamp":1767134908267,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":29,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd007877.pub2","type":"reference-entry","created":{"date-parts":[[2010,1,18]],"date-time":"2010-01-18T15:19:23Z","timestamp":1263827963000},"source":"Crossref","is-referenced-by-count":18,"title":["Haemostatic drugs for traumatic brain injury"],"prefix":"10.1002","author":[{"given":"Pablo","family":"Perel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haleema","family":"Shakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bandit","family":"Thinkhamrop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nakornchai","family":"Phuenpathom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surakrant","family":"Yutthakasemsunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,1,20]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD007877.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1186\/cc6092","article-title":"Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial","volume":"11","author":"Kluger","year":"2007","journal-title":"Critical Care"},{"issue":"6","key":"10.1002\/14651858.CD007877.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1089\/neu.2007.0385","article-title":"Progression of traumatic intracerebral hemorrhage: a prospective observational study","volume":"25","author":"Narayan","year":"2008","journal-title":"Journal of Neurotrauma"},{"issue":"3-4","key":"10.1002\/14651858.CD007877.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01808960","article-title":"Proteolytic enzyme activity in patients with severe head injury and the effect of a proteinase inhibitor","volume":"49","author":"Auer","year":"1979","journal-title":"Acta Neurochirurgica"},{"key":"10.1002\/14651858.CD007877.pub2-BIB4|cit4","unstructured":"CRASH-2. Ongoing study"},{"key":"10.1002\/14651858.CD007877.pub2-BIB5|cit5","unstructured":"Tranexamic Acid for Preventing Progressive Intracranial Haemorrhage in Traumatic Brain Injury. Ongoing study"},{"issue":"11","key":"10.1002\/14651858.CD007877.pub2-BIB6|cit6","first-page":"1107","article-title":"\"Ultra-early\" antifibrinolytic treatment of subarachnoidal bleeding with tranexamic acid","volume":"168","author":"Astrup","year":"2006","journal-title":"Ugeskrift for Laeger"},{"key":"10.1002\/14651858.CD007877.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.TA.0000171453.37949.B7","article-title":"Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized placebo controlled double blind clinical trials","volume":"59","author":"Boffard","year":"2005","journal-title":"Journal of Trauma"},{"issue":"3","key":"10.1002\/14651858.CD007877.pub2-BIB8|cit8","first-page":"25-46; discussi","article-title":"Surgical management of traumatic parenchymal lesions","volume":"58 Suppl","author":"Bullock","year":"2006","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1002\/14651858.CD007877.pub2-BIB9|cit9","first-page":"85","article-title":"Non operative management of acute extradural hematomas in children","volume":"36","author":"Ceylan","year":"1992","journal-title":"Journal of Neurosurgical Science"},{"issue":"4","key":"10.1002\/14651858.CD007877.pub2-BIB10|cit10","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004896.pub2","article-title":"Antifibrinolytic drugs for acute traumatic injury","author":"Coats","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9475","key":"10.1002\/14651858.CD007877.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0140-6736(05)66552-X","article-title":"Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months","volume":"365","author":"Edwards","year":"2005","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD007877.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1371\/journal.pctr.0010030","article-title":"Improving the evidence base for trauma care: progress in the international CRASH-2 trial","volume":"1","year":"2006","journal-title":"PLoS Clinical Trials"},{"key":"10.1002\/14651858.CD007877.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/emj.2007.057158","article-title":"Recombinant activated factor VII use in the emergency department","volume":"25","author":"Fishman","year":"2008","journal-title":"Emergency Medicine Journal"},{"issue":"9233","key":"10.1002\/14651858.CD007877.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(00)02689-1","article-title":"Traumatic brain injury","volume":"356","author":"Ghajar","year":"2000","journal-title":"Lancet"},{"issue":"4. Art. No.: CD","key":"10.1002\/14651858.CD007877.pub2-BIB15|cit15","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001886.pub2","article-title":"Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion","author":"Henry","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007877.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/cc2407","article-title":"Methods for improved hemorrhage control","volume":"8 Suppl 2","author":"Holcomb","year":"2004","journal-title":"Critical Care"},{"issue":"5","key":"10.1002\/14651858.CD007877.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3233\/NRE-2007-22502","article-title":"The impact of traumatic brain injuries: a global perspective","volume":"22","author":"Hyder","year":"2007","journal-title":"NeuroRehabilitation"},{"key":"10.1002\/14651858.CD007877.pub2-BIB18|cit18","doi-asserted-by":"crossref","unstructured":"Langlois JA Rutland-Brown W Thomas KE Traumatic brain injury in the United States: emergency department visits, hospitalizations, and deaths Atlanta (GA): Centers for Disease Control and Prevention, National Center for Injury Prevention and Control; 2006","DOI":"10.1037\/e721222007-001"},{"issue":"2","key":"10.1002\/14651858.CD007877.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1089\/neu.2006.0024","article-title":"Prognosis and clinical trial design in traumatic brain injury: the IMPACT study","volume":"24","author":"Maas","year":"2007","journal-title":"Journal of Neurotrauma"},{"issue":"5","key":"10.1002\/14651858.CD007877.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"267-9; discussi","DOI":"10.1007\/s003810050389","article-title":"Surgery or conservative treatment in children with traumatic intracerebral haematoma","volume":"15","author":"Mandera","year":"1999","journal-title":"Child's Nervous System"},{"issue":"22","key":"10.1002\/14651858.CD007877.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1056\/NEJMra067742","article-title":"Prevention and treatment of major blood loss","volume":"356","author":"Mannucci","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"20","key":"10.1002\/14651858.CD007877.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa0707534","article-title":"Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage","volume":"358","author":"Mayer","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"7641","key":"10.1002\/14651858.CD007877.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/bmj.39461.643438.25","article-title":"Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients","volume":"336","author":"Perel","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007877.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/jcp.33.Suppl_14.35","article-title":"Basis of antifibrinolytic therapy","volume":"14","author":"Prentice","year":"1980","journal-title":"Journal of Clinical Pathology. Supplement"},{"issue":"2","key":"10.1002\/14651858.CD007877.pub2-BIB25|cit25","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001245","article-title":"Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage","author":"Roos","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007877.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/(SICI)1096-8652(199709)56:1<32::AID-AJH7>3.0.CO;2-3","article-title":"Antifibrinolytic drugs and perioperative hemostasis","volume":"56","author":"Slaughter","year":"1997","journal-title":"American Journal of Hematology"},{"issue":"2","key":"10.1002\/14651858.CD007877.pub2-BIB27|cit27","article-title":"Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia","author":"Stanworth","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007877.pub2-BIB28|cit28","unstructured":"Surakrant Y Tranexamic Acid for Preventing Progressive Intracranial Haemorrhage in Traumatic Brain Injury Accessed at http:\/\/clinicaltrials.gov\/"},{"issue":"3","key":"10.1002\/14651858.CD007877.pub2-BIB29|cit29","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005951.pub2","article-title":"Haemostatic drug therapies for acute primary intracerebral haemorrhage","author":"You","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd007877.pub3","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T00:00:00Z","timestamp":1431475200000},"record-id":"32234"},{"DOI":"10.1002\/14651858.cd007877.pub3","type":"withdrawal","label":"Withdrawal","source":"publisher","updated":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T00:00:00Z","timestamp":1431475200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD007877.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:14:43Z","timestamp":1628532883000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007877.pub2"}},"subtitle":[],"editor":[{"given":"Pablo","family":"Perel","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,1,20]]},"references-count":29,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007877.pub2","relation":{},"subject":[],"published":{"date-parts":[[2010,1,20]]}}}